New proton beam therapy aims to cut side effects in prostate cancer treatment
NCT ID NCT04725903
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a precise type of radiation called proton therapy for men with high-risk prostate cancer that has spread to lymph nodes. The goal is to see if targeting the tumor and nearby lymph nodes with protons causes fewer bowel and urinary side effects than standard radiation. About 30 participants will receive the treatment and be monitored for side effects within the first month.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University Hospital/Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Man's best friend as cancer detector: can dogs sniff out prostate cancer?
- Can a single radiation type spare prostate cancer patients from extra side effects?
- Precision radiation may tame rising PSA after prostate surgery
- Hormone therapy plus precision radiation aims to crush prostate cancer early
- Double-Dose precision: new combo radiation aims to shrink prostate tumors faster
- Freezing or heating prostate tumors: a targeted alternative to surgery?